Ear News and Research

RSS

Mount Sinai study could transform treatment for patients with retinal degenerative diseases

Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.

16 Aug 2018

Researchers identify way to grow immune cells at large scale for preventing cancer reoccurrence

For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

15 Aug 2018

Innovative oncofertility program launched by RMA of New York and Mount Sinai Health System

Reproductive Medicine Associates of New York, a Manhattan-based fertility center, and the Mount Sinai Health System have launched an innovative, integrated oncofertility program at The Blavatnik Family – Chelsea Medical Center at Mount Sinai to provide individuals and couples the benefit of advanced medical technologies to help with someday building their families.

15 Aug 2018

Phonak's new smallest and most discreet Virto B-Titanium hearing aid

In February of 2017, Phonak announced production of the Virto B-Titanium hearing aid. Virto B-Titanium remains the world’s only mainstream custom hearing aid made of premium medical-grade titanium. Virto B-Titanium combines the many benefits of titanium—including superior strength and an extra lightweight—together with the latest 3D printing technology.

From Phonak LLC 14 Aug 2018

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease in individuals who do not have asthma.

14 Aug 2018

Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes

Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.

14 Aug 2018

AI platform identifies acute neurological illnesses faster than human diagnosis

An artificial intelligence platform designed to identify a broad range of acute neurological illnesses, such as stroke, hemorrhage, and hydrocephalus, was shown to identify disease in CT scans in 1.2 seconds, faster than human diagnosis, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the journal Nature Medicine.

14 Aug 2018

GN Hearing unveils world's first Premium-Plus hearing aid

GN Hearing today unveils the world's first Premium-Plus hearing aid: ReSound LiNX Quattro, designed for people who want the very best that technology has to offer and desire a brilliant sound experience with great speech intelligibility even in noisy situations.

13 Aug 2018

NIH awards $6.5 million to establish multi-institution biomedical technology resource center

The National Institutes of Health have awarded $6.5 million to a consortium that includes the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai, the University of Washington, the University of Connecticut, and the University of Auckland, New Zealand, to establish the Center for Reproducible Biomedical Modeling.

13 Aug 2018

Autoimmune response drives neurodegeneration in glaucoma

A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vision loss from glaucoma, the second leading cause of irreversible blindness in the world.

12 Aug 2018

Autoimmune response contributes to vision loss in glaucoma patients

A research team from Massachusetts Eye and Ear and MIT has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vision loss from glaucoma, the second leading cause of irreversible blindness in the world.

10 Aug 2018

Glaucoma could be an autoimmune disorder, study suggests

Glaucoma, a disease that afflicts nearly 70 million people worldwide, is something of a mystery despite its prevalence. Little is known about the origins of the disease, which damages the retina and optic nerve and can lead to blindness.

10 Aug 2018

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to results from a clinical trial published in JCO Precision Oncology in August.

9 Aug 2018

Injecting vasoactive intestinal peptide into the eye enhances corneal graft survival

A new study in the American Journal of Pathology reports for the first time that injection of neuropeptide vasoactive intestinal peptide directly into the eye of mice enhanced corneal graft survival.

7 Aug 2018

Scientists solve 60-year-old mystery of how thalidomide caused birth defects

More than 60 years after the drug thalidomide caused birth defects in thousands of children whose mothers took the drug while pregnant, scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?

2 Aug 2018

New drug cocktails make targeted cancer therapies more efficient with less side effects

Mount Sinai researchers have discovered that certain drug cocktails help targeted therapies attack cancer more efficiently while lessening common side effects, according to a study published today in Cancer Research.

1 Aug 2018

Researchers investigate how afferent nerves that sprout from the ectopic ear reach the brain

In vertebrates, the inner ear develops from the otic placode, a group of cells found in a specific region on the surface of the growing embryo.

27 Jul 2018

The Mount Sinai Hospital receives accreditation as geriatric emergency department

The Department of Emergency Medicine at The Mount Sinai Hospital is the first in New York State to be accredited as a geriatric emergency department by the American College of Emergency Physicians. Eight emergency departments in the nation received this accreditation, which is part of a nationwide effort to improve and standardize emergency care for elderly patients.

20 Jul 2018

Health impact of highly processed summertime staples

With the 4th of July in the rearview mirror and Labor Day coming down the pike, barbecue season is in full swing.

19 Jul 2018

Deleting single gene in gut bacteria affects metabolism, reduces weight gain in mice

Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice, according to a study in the journal eLife.

18 Jul 2018

Ear News and Research

Mount Sinai study could transform treatment for patients with retinal degenerative diseases

Researchers identify way to grow immune cells at large scale for preventing cancer reoccurrence

Innovative oncofertility program launched by RMA of New York and Mount Sinai Health System

Phonak's new smallest and most discreet Virto B-Titanium hearing aid

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes

AI platform identifies acute neurological illnesses faster than human diagnosis

GN Hearing unveils world's first Premium-Plus hearing aid

NIH awards $6.5 million to establish multi-institution biomedical technology resource center

Autoimmune response drives neurodegeneration in glaucoma

Autoimmune response contributes to vision loss in glaucoma patients

Glaucoma could be an autoimmune disorder, study suggests

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Injecting vasoactive intestinal peptide into the eye enhances corneal graft survival

Scientists solve 60-year-old mystery of how thalidomide caused birth defects

New drug cocktails make targeted cancer therapies more efficient with less side effects

Researchers investigate how afferent nerves that sprout from the ectopic ear reach the brain

The Mount Sinai Hospital receives accreditation as geriatric emergency department

Health impact of highly processed summertime staples

Deleting single gene in gut bacteria affects metabolism, reduces weight gain in mice

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News